PUMA induction by p73 mediates response and resistance of colorectal cancer to anti-EGFR antibody therapy

被引:0
|
作者
Knickelbein, Kyle [1 ]
Tong, Jingshan [1 ]
Chen, Dongshi [1 ]
Wang, Yi-Jun [1 ]
Misale, Sandra [2 ]
Bardelli, Alberto [3 ]
Yu, Jian [1 ]
Zhang, Lin [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] IRCCS, Candiolo Canc Inst FPO, Candiolo, TO, Italy
关键词
D O I
10.1158/1538-7445.AM2018-2861
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2861
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
    Knickelbein, Kyle
    Tong, Jingshan
    Chen, Dongshi
    Wang, Yi-Jun
    Misale, Sandra
    Bardelli, Alberto
    Yu, Jian
    Zhang, Lin
    ONCOGENE, 2018, 37 (33) : 4599 - 4610
  • [2] Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
    Kyle Knickelbein
    Jingshan Tong
    Dongshi Chen
    Yi-Jun Wang
    Sandra Misale
    Alberto Bardelli
    Jian Yu
    Lin Zhang
    Oncogene, 2018, 37 : 4599 - 4610
  • [3] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer
    Zhao, Ben
    Wang, Lu
    Qiu, Hong
    Zhang, Mingsheng
    Sun, Li
    Peng, Ping
    Yu, Qianqian
    Yuan, Xianglin
    ONCOTARGET, 2017, 8 (03) : 3980 - 4000
  • [4] Markers of resistance to anti-EGFR therapy in colorectal cancer
    Shaib, Walid
    Mahajan, Reena
    El-Rayes, Bassel
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2013, 4 (03) : 308 - 318
  • [5] Correction: Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
    Kyle Knickelbein
    Jingshan Tong
    Dongshi Chen
    Yi-Jun Wang
    Sandra Misale
    Alberto Bardelli
    Jian Yu
    Lin Zhang
    Oncogene, 2023, 42 : 1957 - 1957
  • [6] Drivers of secondary resistance to anti-EGFR therapy in metastatic colorectal cancer
    Noseir, Soha Hussein
    Hahn, Stephan
    Maghnouj, Abdelouahid
    Ladigan, Swetlana
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Drivers of Secondary Resistance to Anti-Egfr Therapy in Metastatic Colorectal Cancer
    Noseir, Soha
    Hahn, Stephan
    Maghnouj, Abdelonahid
    Ladigan, Swetlana
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 219 - 219
  • [8] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Zacharenia Saridaki
    Vassilis Georgoulias
    John Souglakos
    World Journal of Gastroenterology, 2010, 16 (10) : 1177 - 1187
  • [9] Optimizing Anti-EGFR Therapy in Colorectal Cancer
    Salazar, Ramon
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5415 - 5416
  • [10] Mutational signatures impact the evolution of anti-EGFR antibody resistance in colorectal cancer
    Woolston, Andrew
    Barber, Louise J.
    Griffiths, Beatrice
    Pich, Oriol
    Lopez-Bigas, Nuria
    Matthews, Nik
    Rao, Sheela
    Watkins, David
    Chau, Ian
    Starling, Naureen
    Cunningham, David
    Gerlinger, Marco
    NATURE ECOLOGY & EVOLUTION, 2021, 5 (07) : 1024 - +